Ranger Investment Management - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ranger Investment Management ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$24,782,795
+3.4%
426,848
-4.1%
1.64%
+14.1%
Q2 2023$23,962,801
+380.5%
445,157
+254.5%
1.44%
+331.7%
Q1 2023$4,987,084
+2.3%
125,556
+3.6%
0.33%
-7.7%
Q4 2022$4,875,313
+28.0%
121,186
+2.3%
0.36%
+21.1%
Q3 2022$3,809,000
+6.4%
118,510
-1.8%
0.30%
+10.3%
Q2 2022$3,579,000
+8.1%
120,641
+2.4%
0.27%
+29.7%
Q1 2022$3,311,000
-35.1%
117,801
+6.4%
0.21%
-25.1%
Q4 2021$5,103,000
+40.4%
110,751
+0.0%
0.28%
+43.8%
Q3 2021$3,634,000
-1.2%
110,726
+5.5%
0.19%
+1.0%
Q2 2021$3,678,000
-3.4%
104,941
-0.4%
0.19%
-8.6%
Q1 2021$3,808,000
+22.8%
105,381
-1.3%
0.21%
+28.0%
Q4 2020$3,102,000
-11.9%
106,802
-14.4%
0.16%
-26.8%
Q3 2020$3,520,000
+57.2%
124,763
+80.2%
0.22%
+46.4%
Q2 2020$2,239,000
-43.4%
69,236
-28.7%
0.15%
-56.0%
Q1 2020$3,956,000
-29.0%
97,111
+7.5%
0.35%
-5.2%
Q4 2019$5,571,000
-18.4%
90,339
-3.5%
0.37%
-24.9%
Q3 2019$6,826,000
-7.9%
93,664
+3.9%
0.49%
-3.2%
Q2 2019$7,410,000
+21.4%
90,140
+4.2%
0.50%
+14.5%
Q1 2019$6,103,000
+69.8%
86,517
+8.3%
0.44%
+50.5%
Q4 2018$3,595,000
-9.4%
79,852
+13.7%
0.29%
+11.8%
Q3 2018$3,970,000
-0.9%
70,212
+17.0%
0.26%
-6.4%
Q2 2018$4,008,000
+39.9%
60,000
+21.9%
0.28%
+32.1%
Q1 2018$2,865,000
+12.6%
49,217
+24.6%
0.21%
+13.4%
Q4 2017$2,545,000
+31.4%
39,487
+7.0%
0.19%
+29.0%
Q3 2017$1,937,000
+83.1%
36,894
+63.1%
0.14%
+93.3%
Q2 2017$1,058,000
+37.6%
22,614
+45.6%
0.08%
+33.9%
Q1 2017$769,00015,5300.06%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders